In last trading session, Tango Therapeutics Inc (NASDAQ:TNGX) saw 1.07 million shares changing hands with its beta currently measuring 0.77. Company’s recent per share price level of $2.79 trading at -$0.12 or -4.12% at ring of the bell on the day assigns it a market valuation of $299.70M. That closing price of TNGX’s stock is at a discount of -366.31% from its 52-week high price of $13.01 and is indicating a premium of 3.23% from its 52-week low price of $2.70. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.35 million shares which gives us an average trading volume of 1.84 million if we extend that period to 3-months.
For Tango Therapeutics Inc (TNGX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.11. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.34 in the current quarter.
Tango Therapeutics Inc (NASDAQ:TNGX) trade information
Upright in the red during last session for losing -4.12%, in the last five days TNGX remained trading in the red while hitting it’s week-highest on Monday, 12/16/24 when the stock touched $2.79 price level, adding 15.2% to its value on the day. Tango Therapeutics Inc’s shares saw a change of -71.82% in year-to-date performance and have moved -10.00% in past 5-day. Tango Therapeutics Inc (NASDAQ:TNGX) showed a performance of -22.50% in past 30-days. Number of shares sold short was 7.22 million shares which calculate 2.31 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 15.5 to the stock, which implies a rise of 82.0% to its current value. Analysts have been projecting 13 as a low price target for the stock while placing it at a high target of 18. It follows that stock’s current price would drop -365.95% in reaching the projected high whereas dropping to the targeted low would mean a loss of -365.95% for stock’s current value.
Tango Therapeutics Inc (TNGX) estimates and forecasts
Statistics highlight that Tango Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -70.79% of value to its shares in past 6 months, showing an annual growth rate of -10.19% while that of industry is 17.30. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 25.91% from the last financial year’s standing.
9 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 8.02M for the same. And 5 analysts are in estimates of company making revenue of 7.37M in the next quarter. Company posted 5.43M and 6.47M of sales in current and next quarters respectively a year earlier.
Tango Therapeutics Inc (NASDAQ:TNGX)’s Major holders
Insiders are in possession of 12.84% of company’s total shares while institution are holding 100.71 percent of that, with stock having share float percentage of 115.55%. Investors also watch the number of corporate investors in a company very closely, which is 100.71% institutions for Tango Therapeutics Inc that are currently holding shares of the company. TRV GP IV, LLC is the top institutional holder at TNGX for having 19.2 million shares of worth $164.75 million. And as of 2024-06-30, it was holding 17.751 of the company’s outstanding shares.
The second largest institutional holder is ECOR1 CAPITAL, LLC, which was holding about 13.33 million shares on 2024-06-30. The number of shares represents firm’s hold over 12.3237 of outstanding shares, having a total worth of $114.38 million.
